| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.dragarwal.com | |
| Market Cap | 1,542.54 Cr. | |
| Enterprise Value(EV) | 1,544.35 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 100.53 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 32.65 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 66.57 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 311.55 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 10.53 | Calculated using Price: 3,282.00 |
| Dividend Yield | 0.09 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.47 Cr. | 4,700,000 Shares |
| FaceValue | 10 | |
| About Dr Agarwals Eye Hospital Ltd. | ||
| Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans. | ||
| 1 Day |
|
+3.04% |
| 1 Week |
|
+0.27% |
| 1 Month |
|
+9.47% |
| 3 Month |
|
+1.02% |
| 6 Month |
|
+16.19% |
| 1 Year |
|
+192.92% |
| 2 Year |
|
+352.70% |
| 5 Year |
|
+837.33% |
| 10 Year |
|
+4826.47% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 26.67 | 0.16 | 27.78 | 21.02 | 29.55 | 26.91 | -2.6 | 36.29 | 38.56 | |
| Return on Capital Employed (%) | 18.81 | 7.7 | 28.26 | 31.7 | 34.3 | 39.87 | 16.92 | 42.4 | 42.98 | |
| Return on Assets (%) | 8.53 | 0.05 | 8.87 | 7.65 | 11.01 | 9.55 | -0.86 | 9.63 | 9.78 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 24 | 23 | 29 | 35 | 46 | 56 | 55 | 78 | 113 | 137 | |
| Non Curr. Liab. | 13 | 25 | 24 | 24 | 40 | 71 | 42 | 173 | 212 | 217 | |
| Curr. Liab. | 31 | 36 | 27 | 37 | 35 | 39 | 70 | 82 | 96 | 63 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 422 | 417 | |
| Non Curr. Assets | 44 | 61 | 61 | 73 | 91 | 136 | 123 | 283 | 375 | 358 | |
| Curr. Assets | 23 | 24 | 20 | 23 | 30 | 30 | 44 | 50 | 47 | 59 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 67 | 84 | 81 | 96 | 120 | 166 | 167 | 333 | 422 | 417 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 118 | 137 | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 306 | |
| Other Income | 0 | 0 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 5 | |
| Total Income | 118 | 137 | 150 | 156 | 172 | 179 | 142 | 202 | 270 | 311 | |
| Total Expenditure | -103 | -121 | -126 | -129 | -140 | -129 | -110 | -143 | -192 | -220 | |
| PBIDT | 15 | 15 | 24 | 27 | 32 | 50 | 32 | 60 | 78 | 91 | |
| Interest | -4 | -5 | -4 | -3 | -4 | -9 | -7 | -7 | -8 | -7 | |
| Depreciation | -6 | -11 | -9 | -10 | -11 | -21 | -19 | -20 | -20 | -21 | |
| Taxation | 0 | 1 | -4 | -7 | -6 | -6 | -7 | -8 | -12 | -16 | |
| Exceptional Items | |||||||||||
| PAT | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 47 | |
| Adjusted EPS | 12 | 0 | 16 | 14 | 25 | 29 | -3 | 51 | 79 | 101 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 12 | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | |
| Cash Fr. Inv. | -11 | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | |
| Cash Fr. Finan. | -3 | -5 | 0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | |
| Net Change | -3 | -1 | 0 | 0 | 0 | 2 | 2 | 15 | 7 | -1 | |
| Cash & Cash Eqvt | 3 | 1 | 2 | 2 | 2 | 4 | 6 | 22 | 28 | 27 |
|
Thu, 18 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Disclosure under Regulation 39(3) of the SEBI (LODR) Regulations 2015. |
|
Thu, 18 Apr 2024
Board Meeting Intimation for Approving Audited Financial Results For The Quarter And Year Ended 31St March 2024 And Recommendation Of Final Dividend If Any For The Financial Year 2023-24. DR.AGARWALS EYE HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2024 and recommendation of Dividend if any for the Financial Year 2023-24. |
|
Wed, 17 Apr 2024
Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations 2015 As per the letter enclosed. |
| Fri, 19 Apr 2024 |
High Delivery Percentage
|
Opening at Low
|
Close Within 52 Week High Zone
|
High Increase in 1 Month
|
High Increase in 1 Year
|
